Real-life experience with first-line treatment with daratumumab, bortezomib, melphalan, and prednisone in patients with newly diagnosed multiple myeloma ineligible for autologous stem-cell transplantation
Amalia Domingo‐González, Rafael Alonso, Ana Jiménez, Teresa de Soto Álvarez et autres
es (code pays fourni par la source)